Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid β-peptides in human cerebrospinal fluid
暂无分享,去创建一个
K. Blennow | H. Zetterberg | E. Portelius | G. Larson | A. Westman-Brinkmalm | G. Brinkmalm | J. Nilsson | Adnan Halim | U. Rüetschi | A. Westman‐Brinkmalm
[1] K. Blennow,et al. A novel pathway for amyloid precursor protein processing , 2011, Neurobiology of Aging.
[2] J. Morris,et al. Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease , 2010, Science.
[3] Xulun Zhang,et al. Activation and intrinsic γ-secretase activity of presenilin 1 , 2010, Proceedings of the National Academy of Sciences.
[4] E. Bennett,et al. O-Glycosylation Modulates Proprotein Convertase Activation of Angiopoietin-like Protein 3 , 2010, The Journal of Biological Chemistry.
[5] L. Tabak. The role of mucin-type O-glycans in eukaryotic development. , 2010, Seminars in cell & developmental biology.
[6] K. Zarschler,et al. Protein tyrosine O-glycosylation--a rather unexplored prokaryotic glycosylation system. , 2010, Glycobiology.
[7] B. Weinhold,et al. Synaptic cell adhesion molecule SynCAM 1 is a target for polysialylation in postnatal mouse brain , 2010, Proceedings of the National Academy of Sciences.
[8] R. Schnaar. Brain gangliosides in axon–myelin stability and axon regeneration , 2010, FEBS letters.
[9] K. Blennow,et al. Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer’s disease , 2010, Acta Neuropathologica.
[10] Henrik Zetterberg,et al. A novel Aβ isoform pattern in CSF reflects γ-secretase inhibition in Alzheimer disease , 2010, Alzheimer's Research & Therapy.
[11] M. Weiner,et al. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease , 2010, Nature Reviews Neurology.
[12] B. Strooper,et al. The secretases: enzymes with therapeutic potential in Alzheimer disease , 2010, Nature Reviews Neurology.
[13] A. Dell,et al. The plasma von Willebrand factor O‐glycome comprises a surprising variety of structures including ABH antigens and disialosyl motifs , 2010, Journal of thrombosis and haemostasis : JTH.
[14] C. Hesse,et al. Enrichment of glycopeptides for glycan structure and attachment site identification , 2009, Nature Methods.
[15] B. Weinhold,et al. Brain development needs sugar: the role of polysialic acid in controlling NCAM functions , 2009, Biological chemistry.
[16] Michael Przybylski,et al. Elucidation of O-glycosylation structures of the beta-amyloid precursor protein by liquid chromatography-mass spectrometry using electron transfer dissociation and collision induced dissociation. , 2009, Journal of proteome research.
[17] A. G. Semenov,et al. Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site. , 2009, Clinical chemistry.
[18] Henrik Zetterberg,et al. P1-401: Identification of novel APP/Aβ isoforms in human cerebrospinal fluid , 2008, Alzheimer's & Dementia.
[19] Y. Sakurai,et al. Increased bisecting and core-fucosylated N-glycans on mutant human amyloid precursor proteins , 2008, Glycoconjugate Journal.
[20] S. Ingrand,et al. Genotype-related changes of ganglioside composition in brain regions of transgenic mouse models of Alzheimer's disease , 2007, Neurobiology of Aging.
[21] Henrik Zetterberg,et al. Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry. , 2007, Journal of proteome research.
[22] J. Kaplan,et al. O-Linked Glycosylation at Threonine 27 Protects the Copper Transporter hCTR1 from Proteolytic Cleavage in Mammalian Cells* , 2007, Journal of Biological Chemistry.
[23] K. Blennow,et al. Cerebrospinal fluid β-amyloid 1–42 concentration may predict cognitive decline in older women , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[24] Henrik Zetterberg,et al. Determination of β-Amyloid Peptide Signatures in Cerebrospinal Fluid Using Immunoprecipitation-Mass Spectrometry , 2006 .
[25] K. Blennow,et al. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study , 2006, The Lancet Neurology.
[26] D. Selkoe,et al. Amyloid β-Protein Is Degraded by Cellular Angiotensin-converting Enzyme (ACE) and Elevated by an ACE Inhibitor* , 2005, Journal of Biological Chemistry.
[27] K. Blennow,et al. Structural membrane alterations in Alzheimer brains found to be associated with regional disease development; increased density of gangliosides GM1 and GM2 and loss of cholesterol in detergent‐resistant membrane domains , 2005, Journal of neurochemistry.
[28] M. Fukuda,et al. Polysialic Acid and Mucin Type O-Glycans on the Neural Cell Adhesion Molecule Differentially Regulate Myoblast Fusion* , 2003, Journal of Biological Chemistry.
[29] H. Bock,et al. Differential Glycosylation Regulates Processing of Lipoprotein Receptors by γ-Secretase* , 2003, Journal of Biological Chemistry.
[30] Joseph L Goldstein,et al. Regulated Intramembrane Proteolysis A Control Mechanism Conserved from Bacteria to Humans , 2000, Cell.
[31] T. Saido,et al. Identification of the major Aβ1–42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition , 2000, Nature Medicine.
[32] S. Spitalnik,et al. Study of the sugar chains of recombinant human amyloid precursor protein produced by Chinese hamster ovary cells. , 1999, Biochimica et biophysica acta.
[33] R. Zubarev,et al. Localization of O-glycosylation sites in peptides by electron capture dissociation in a Fourier transform mass spectrometer. , 1999, Analytical chemistry.
[34] L. Hersh,et al. Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation* , 1998, The Journal of Biological Chemistry.
[35] S. Spitalnik,et al. The role of glycosylation in synthesis and secretion of beta-amyloid precursor protein by Chinese hamster ovary cells. , 1996, Archives of biochemistry and biophysics.
[36] P. Greengard,et al. Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[37] S. Sisodia. Beta-amyloid precursor protein cleavage by a membrane-bound protease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[38] P. Cohen,et al. Isolation and structural analysis of a peptide containing the novel tyrosyl‐glucose linkage in glycogenin. , 1988, The EMBO journal.
[39] A. Dell,et al. Structures of novel sialylated O-linked oligosaccharides isolated from human erythrocyte glycophorins. , 1987, The Journal of biological chemistry.
[40] H. Wiśniewski,et al. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[41] H. Egge,et al. Natural occurrence of ganglioside lactones. Isolation and characterization of GD1b inner ester from adult human brain. , 1986, The Journal of biological chemistry.
[42] M. Aon,et al. Protein-bound glycogen is linked to tyrosine residues. , 1985, The Biochemical journal.
[43] J. Finne. Occurrence of unique polysialosyl carbohydrate units in glycoproteins of developing brain. , 1982, The Journal of biological chemistry.
[44] S. Inoue,et al. Isolation of a novel glycoprotein from the eggs of rainbow trout: occurrence of disialosyl groups on all carbohydrate chains. , 1978, Biochemical and biophysical research communications.
[45] H. Bock,et al. Differential glycosylation regulates processing of lipoprotein receptors by gamma-secretase. , 2003, The Journal of biological chemistry.
[46] M. Wolfe. The secretases of Alzheimer's disease. , 2003, Current topics in developmental biology.